Corteva (CTVA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTVA Corteva

Watchlist

62.240
-0.260-0.42%

Close Nov 29 13:00 ET

62.000
-0.240-0.39%

Post 17:01 ET

42.78BMarket Cap62.87P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Corteva To Go Ex-Dividend On December 2nd, 2024 With 0.17 USD Dividend Per Share
Moomoo NewsNov 28 20:00 ET
Corteva Insider Sold Shares Worth $2,388,367, According to a Recent SEC Filing
MT NewswiresNov 27 16:20 ET
Evogene Says Corteva Terminates Licensing Agreement of Lavie Bio Subsidiary
TipRanksNov 27 16:10 ET
Wednesday Ends With Index Decline | Wall Street Today
Kevin TraversNov 27 16:08 ET
Express News | Evogene Ltd: Unit Receives Notice of Termination of Licensing Agreement With Corteva for Bio Fungicide Lead Candidates
ReutersNov 27 16:04 ET
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Kevin TraversNov 27 09:57 ET

Comments

Bull X Bear

Oct 16 09:41

Top Picks for US Stocks 🎯

Will Nvidia dethrone Apple as world's most valuable company?

Movers and Shakers

Apr 12 07:23

Columns Today's Morning Movers and Top Ratings: JPM, C, WFC, GTLB and More

Morning Movers
Gapping up
$Citigroup (C.US)$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock (BLK.US)$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life (GL.US)$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...

Moomoo AI

Mar 22 09:32

Corteva's rising ROCE and efficient capital use are promising, but growing current liabilities may pose new risks. Despite this, the stock has given a decent 23% return over the past three years, indicating these developments are gaining deserved attention.

Returns Are Gaining Momentum At Corteva (NYSE:CTVA)

Moomoo AI

Mar 4 04:27

Corteva's high P/E ratio is sustained by its projected growth surpassing the broader market. Shareholders are at ease with the P/E, confident in the company's future earnings. The share price isn't anticipated to drop significantly soon under these conditions.

Corteva, Inc. (NYSE:CTVA) Not Lagging Market On Growth Or Pricing

Moomoo AI

Feb 28 06:06

The CEO of Lavie Bio, Amit Noam, expressed satisfaction at achieving this milestone with Corteva, stating that the agreement showcases Lavie Bio's technological capabilities and enables the swift introduction of groundbreaking ag-biological solutions.

Press Release: Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M After Meeting Corteva's Licensing Agreement Requirements

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CTVA Corteva

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target